hotspot -WSS

hotspot

author：explore 2025-10-02 21:05:32 - browse：193

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Police still searching for prisoner who escaped from NYC hospital

focus

WSS

UnitedHealth increases loan offers after Change Healthcare outage

AstraZeneca to buy developer of next

The best solution to the drug shortages problem

Readout Newsletter: Bluebird, CVS, Contineum

Plastic surgeons increase patient psychiatric screenings

Stop the failed accountable care organization experiment

hotspot

hotspot

focus

ChatGPT in medicine: STAT answers readers' burning questions

Orchard's therapy for neuron disease in children wins FDA approval

Medicare proposal to cover medical devices draws a mixed reaction

The best solution to the drug shortages problem

What does generative AI mean for health care? We asked experts

Baby aspirin cuts fat buildup in liver disease patients, in small study

BioMarin wins approval for gene therapy to treat hemophilia A

Why failed clinical trials don’t always spell doom for a new drug

Sports medicine is finally prioritizing gender equality

FDA panel issues narrow recommendation for Covid vaccine booster doses

knowledge

Future doctors should be trained to promote social change

What to know about Virgin Galactic's 1st mission taking paying customers to space

Police still searching for prisoner who escaped from NYC hospital

Virtual Event: March of the Biosimilars

Creating egg and sperm cells from stem cells raises ethical issues

Physicians and social media: If you see something, say something?

entertainment

hotspot

focus

entertainment